Ann: Proposed issue of securities - CYP, page-22

The same Lonza that got granted a non-exclusive right to use FujiFilm Cellular Dynamics patents related to iPSC generation, including episomal vectors and reprogramming factors, for development and clinical manufacture of iPSC lines for cell therapies back in 2020?
https://www.lonza.com/news/2020-11-12-06-00

Episomal vectors and iPSC generation?
"Cynata’s iPSC bank was manufactured by Cellular Dynamics International (now called Fujifilm CDI), using a non-integrating episomal reprogramming method based on that originally developed at UWM."
https://cynata.com/company-faqs

That was back in 2014, 6 years before Lonza:
https://www.asx.com.au/asxpdf/20140918/pdf/42s92zp5qmrdn3.pdf

And 9 years before NovoNordisk:
https://www.fujifilmcdi.com/news-item/fcdi-license-agreement-with-novo-nordisk

Not to mention Century Therapeutics, IASO Biotherapeutics, Opsis Therapeutics, etc.

So unsafe...

I doubt you can change the smell of the HC cesspool. TipRank, nuff said.